Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia
Open Access
- 25 September 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 320 (12), 1249-1258
- https://doi.org/10.1001/jama.2018.13155
Abstract
Staphylococci are the most commonly identified pathogens in both hospital-acquired and community-onset bloodstream infections.1 Despite its frequency, the optimal duration of treatment for staphylococcal bacteremia is unknown. Consensus guidelines recommend prolonged courses of antibiotics for complicated staphylococcal bacteremia and shorter courses of therapy for uncomplicated staphylococcal bacteremia, but these are primarily based on low-quality evidence and expert opinion.2-4 As a result, there is considerable variation in treatment practices.5This publication has 19 references indexed in Scilit:
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive SummaryClinical Infectious Diseases, 2011
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and ChildrenClinical Infectious Diseases, 2011
- ERRATUMClinical Infectious Diseases, 2010
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusThe New England Journal of Medicine, 2006
- Minimizing the Workup of Blood Culture Contaminants: Implementation and Evaluation of a Laboratory-Based AlgorithmJournal of Clinical Microbiology, 2002
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000